2007 HSCI Seed Grant recipients announced

For the third consecutive year, HSCI awarded seed grants to scientists throughout the Harvard community to provide critical early funding for stem cell research. In June, ten seed grants totaling $1.8 million were awarded to investigators from six HSCI-affiliated institutions (see below), selected from a pool of 66 applicants.

This year’s grants will support stem cell research relating to a host of ubiquitous medical conditions, such as cancer and diseases of the eyes, ears, lungs, and kidneys, as well as investigations aimed at better understanding and harnessing the potential of stem cells for therapeutic purposes.

HSCI’s Seed Grant Program provides two years of funding for projects in areas of stem cell research that will advance HSCI’s mission. A multi-institutional panel conducts a rigorous review process to select the most promising projects. Highest priority is given to projects that are difficult to fund because they are high risk, or that are ineligible for federal support because of restrictions on human embryonic stem cell (hESC) research. The grants are also intended to support junior faculty conducting collaborative research.

In 2007, the Paul Singer Family Foundation made a generous gift of $360,000 to the HSCI Seed Grant Program, specifically to support the work of two investigators conducting hESC research. The recipients of the foundation’s gifts are Dieter Egli, PhD, of Harvard’s Faculty of Arts and Sciences, and Richard Gregory, PhD, of Children’s Hospital Boston.

Since the program’s inception in 2005, HSCI has awarded 35 seed grants totaling $6.3 million. 

2007 HSCI Seed Grant Recipients 

Li Chai, MD, Brigham and Women’s Hospital

Zheng-Yi Chen, PhD, Massachusetts General Hospital

Dieter Egli, PhD, Harvard University Faculty of Arts and Sciences

Richard Gregory, PhD, Children’s Hospital Boston

Benjamin Humphreys, MD, PhD, Brigham and Women’s Hospital

Carla Kim, PhD, Children’s Hospital Boston

Kameran Lashkari, MD, Schepens Eye Research Institute

Stuart Orkin, MD, Children’s Hospital Boston

Sridhar Rao, MD, PhD, Dana-Farber Cancer Institute and Ibrahim Domian, MD, PhD, Massachusetts General Hospital

Sabina Signoretti, MD, Brigham and Women’s Hospital